You just read:

IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma

News provided by

IDM Pharma, Inc.

09 Mar, 2009, 15:44 GMT